Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Crl
  6. /
  7. Akebia Therapeutics, Inc.
CRL
•Akebia Therapeutics, Inc.

Akebia Therapeutics, Inc. – FDA CRL

Record Details

The FDA issued a Complete Response Letter for Akebia Therapeutics, Inc.'s New Drug Application (NDA 215192) for vadadustat tablets, under section 505(b) of the Federal Food, Drug, and Cosmetic Act. The FDA determined that the submitted data do not support a favorable benefit-risk assessment for treating anemia associated with chronic kidney disease in adults, citing significant safety concerns that outweigh the demonstrated efficacy. Key issues included the failure to establish non-inferiority for major adverse cardiac events (MACE) in the non-dialysis-dependent population, a concerning signal for thromboembolic events—particularly vascular access thromboses—in the dialysis-dependent population, and a clinically significant risk for drug-induced liver injury (DILI). The FDA also noted higher use of rescue therapies for worsening anemia with vadadustat and concerns that real-world DILI risks might be underestimated without close monitoring. To address these issues, Akebia Therapeutics must conduct new clinical trial(s) to establish a favorable benefit-risk profile, potentially in a specific patient population or with a revised dosing regimen. Future studies should also assess rescue therapies, rhabdomyolysis, and seizures as adverse events of interest.

Company
Akebia Therapeutics, Inc.
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Debleena Sengupta, PhD, RAC
View Company Profile

ID · 99c36917-e210-4847-8c1e-abd82b3c6138

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Akebia Therapeutics, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.